The Polyurethane Wound Care segmentation by application distinguishes three primary usage groups: acute wounds, chronic wounds, and surgical wounds. Acute wounds—such as traumatic injuries and burns—represent the largest share, accounting for roughly 40% of market revenue due to high incidence rates and the need for rapid, barrier‑forming dressings that protect against infection. Chronic wounds, including diabetic foot ulcers and pressure injuries, contribute about 35% of the market; their prolonged healing cycles drive demand for polyurethane products that maintain a moist environment and enable exudate management. Surgical wounds, comprising post‑operative incisions and minimally invasive procedure sites, occupy the remaining 25%, reflecting steady elective surgery volumes and the preference for polyurethane dressings that provide transparent monitoring and secure adhesion. Collectively, these application categories shape the overall market size, with each segment’s growth linked to demographic trends, healthcare expenditure, and advances in wound‑care protocols.